Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124997012 | 12499701 | 2 | F | 2005 | 20160818 | 20160627 | 20160824 | EXP | FR-UCBSA-2016023656 | UCB | GUINARD E, LIVIDEANU CB, BARTHELEMY H, VIGUIER M, REGUIAI Z, RICHARD MA, ET AL. ACTIVE TUBERCULOSIS IN PSORIASIS PATIENTS TREATED WITH TNF ANTAGONISTS: A FRENCH NATIONWIDE RETROSPECTIVE STUDY. J EUR ACAD DERMATOL VENEREOL. 2016 | 47.00 | YR | M | Y | 0.00000 | 20160825 | MD | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124997012 | 12499701 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | UNKNOWN DOSE | U | U | 125160 | SOLUTION FOR INJECTION | ||||||||
124997012 | 12499701 | 2 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | U | U | 125160 | SOLUTION FOR INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124997012 | 12499701 | 1 | Psoriasis |
124997012 | 12499701 | 2 | Off label use |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124997012 | 12499701 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124997012 | 12499701 | Disseminated tuberculosis | |
124997012 | 12499701 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124997012 | 12499701 | 1 | 2005 | 0 |